Rockville biopharma to sell first product on market in 28 years — but not here

The company got approval from an international regulatory body to launch its injection treatment for patients with multiple myeloma.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.